Clinical Trial

Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma

No Longer Available
View on ClinicalTrials.gov →
Summary
Treatment of a patient with recurrent osteosarcoma with personalized pp65/tumor mRNA RNA-LP under an individual patient expanded access protocol.
Trial Details
NCT Number NCT07560709
Lead Sponsor University of Florida
Conditions Recurrent Osteosarcoma
Updated on ClinicalTrials.gov 2026-05-01